Revenue up 5% over prior year; annual, quarterly results within company guidance
SAN DIEGO, Feb. 26 /PRNewswire-FirstCall/ -- AMN Healthcare Services, Inc. (NYSE: AHS) today announced operating results within guidance for the fourth quarter and full-year 2008. Highlights include:
"Today, AMN Healthcare is growing market share, making investments in the future, and maintaining our strong cash flow and a healthy balance sheet in the economic downturn," said Susan R. Nowakowski, President and Chief Executive Officer of AMN Healthcare. "Our strategy of leveraging the advantages of our size, leadership position, differentiated business model and diversified service lines will allow us to continue outperforming our competitors. It was the execution of this strategy and the dedication of our employees that allowed AMN to increase market share and achieve record revenue and EBITDA results in 2008.
"While not as impacted as many other sectors, the slowing economic conditions and higher unemployment have negatively impacted demand for our services, most notably in nurse staffing," Nowakowski added. "During the first quarter of 2009, we have taken several steps to align our business infrastructure accordingly, focusing on maximizing operating efficiencies and reducing overhead costs, while still preserving our ability to deliver the superior quality and service levels our clients expect from AMN Healthcare."
For the full year 2008, Nurse and Allied revenue was $844 million, up 5% over last year including acquisitions, Locum Tenens revenue was $322 million, up 4%, and Physician Permanent Placement revenue was $51 million, flat with prior year.
For the fourth quarter of 2008, revenue for the Nurse and Allied staffing segment was $207 million, an increase of 5% from the same quarter last year including acquisitions. The Locum Tenens staffing segment generated revenue of $76 million, an increase of 0.3% from the same quarter last year, and the Physician Permanent Placement segment provided revenue of $12 million, a decrease of 7% from the same quarter last year primarily due to a sales reserve adjustment.
Full year gross margin of 26.0% for 2008 remained unchanged from the prior year. Gross margin during the fourth quarter was 25.7% compared to 26.6% for the same quarter last year, mainly reflecting the lower revenue mix from our higher margin business lines such as international nursing and physician permanent placement.
Selling, general and administrative ("SG&A") expenses for the full year 2008 were 18.9% as a percentage of revenue, as compared to 18.7% for 2007. SG&A decreased to 18.6% of revenue in the fourth quarter of 2008 from 19.6% in the same quarter last year due mainly to the effects of cost saving initiatives the company began implementing during the quarter, combined with lower bad debt expense and a favorable actuarial-based insurance reserve adjustment.
For the full year 2008, income tax expense was 43.9% of taxable income as compared to 40.1% for 2007. Income tax expense was 47.5% of taxable income in the fourth quarter as compared to 39.5% in the same quarter last year. These higher effective tax rates reflect the tax matter we identified in the third quarter of 2008.
Full year GAAP diluted earnings per share was $1.02 and included the negative impacts of $0.02 for sales reserve adjustments, $0.03 for restructuring charges and legal expenses associated with our pharmacy staffing business, and $0.04 for the tax matter. Fourth quarter GAAP diluted earnings per share of $0.23 included $0.01 for the sales reserve adjustment and $0.03 expense for the tax matter.
Total debt outstanding at December 31, 2008 was $146.3 million, yielding a leverage ratio of 1.5. Total average diluted shares outstanding for the fourth quarter of 2008 were 32.9 million.
Revenue and Earnings Guidance
The current economic environment is making it more difficult to forecast annual financial performance and to provide meaningful guidance. Therefore, management will continue to share general business trends but will no longer provide specific financial guidance. During the first few months of 2009, the general business trends have been as follows: demand has slowed for most of our business lines, most significantly for nursing, where volumes declined by double-digit percentage amounts both sequentially and year over year. There has also been a moderation in the rate of price increases, though pricing erosion is not expected. Based on these trends, first quarter consolidated revenue is expected to decline in the low to mid-teens, in percentage terms, over prior year.
Nowakowski added, "Our team has been proactively reducing external vendor and internal costs to better align the business infrastructure with the recent and expected lower demand levels to preserve profit margins and cash flow. We are confident that our leadership position combined with our seasoned management, sales and service team, along with our focus on solid financial fundamentals will allow us to continue building market share and successfully weather the challenging economic conditions."
AMN Healthcare Services, Inc. is the largest healthcare staffing company in the United States and the largest nationwide provider in all three of its business segments: travel nurse and allied staffing, locum tenens staffing (temporary physician staffing), and physician permanent placement services. AMN Healthcare recruits healthcare professionals both nationally and internationally and places them on variable lengths of assignments and in permanent positions at acute-care hospitals, physician practice groups and other healthcare settings throughout the United States. For more information, visit http://www.amnhealthcare.com.
Conference Call on February 26, 2008
AMN Healthcare Services, Inc.'s fourth quarter 2008 conference call will be held on Thursday, February 26, 2009, at 5:00 p.m., Eastern Time. A live webcast of the call can be accessed through AMN Healthcare's website at http://www.amnhealthcare.com/investors. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software. Interested parties may participate live via telephone by dialing (800) 230-1059 in the U.S. or (612) 332-1213 internationally. Following the conclusion of the call, a replay of the webcast will be available at the company's website. Alternatively, a telephonic replay of the call will be available at 7:30 p.m. Eastern Time on February 26, 2009, and can be accessed until March 12, 2009 at midnight Eastern Time, by calling (800) 475-6701 in the U.S. or (320) 365-3844 internationally, with access code 982568.
This earnings release contains certain non-GAAP financial information. These measures are not in accordance with, or an alternative to, generally accepted accounting principles in the United States ("GAAP"), and may be different from non-GAAP measures reported by other companies. From time to time, additional information regarding non-GAAP financial measures may be made available on the Company's website at http://www.amnhealthcare.com/investors.
This earnings release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include anticipated first quarter consolidated revenues and expectations, and Ms. Nowakowski's comments including those regarding the company's growing market share, outperforming competitors, not expecting price erosion and preserving profit margin and cash flow. We based these forward-looking statements on our current expectations and projections about future events. Our actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Forward-looking statements are identified by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. The following factors could cause our actual results to differ materially from those implied by the forward-looking statements in this earnings release: our ability to sustain our business in a significant economic downturn; our ability to continue to recruit qualified temporary and permanent healthcare professionals at reasonable costs; our ability to retain qualified temporary healthcare professionals for multiple assignments at reasonable costs; our ability to attract and retain sales and operational personnel; our ability to enter into contracts with hospitals, healthcare facility clients, affiliated healthcare networks and physician practice groups on terms attractive to us and to secure orders related to those contracts; our ability to demonstrate the value of our services to our healthcare and facility clients, which may be impacted by the role of intermediaries such as vendor management companies; the general level of patient occupancy and utilization of services at our hospital and healthcare facility clients' facilities, including the potential impact on such utilization caused by adoption of alternative modes of healthcare delivery, which utilization may influence demand for our services; the overall level of demand for services offered by temporary and permanent healthcare staffing providers; the ability of our hospital, healthcare facility and physician practice group clients to retain and increase the productivity of their permanent staff; the variation in pricing of the healthcare facility contracts under which we place temporary healthcare professionals; our ability to successfully design our strategic growth, acquisition and integration strategies and to implement those strategies, which includes our ability to obtain credit at reasonable terms to complete acquisitions, integrate acquired companies' accounting, management information, human resource and other administrative systems, and implement or remediate controls, procedures and policies at acquired companies; our ability to leverage our cost structure; access to and undisrupted performance of our management information and communication systems, including use of the Internet, and our candidate and client databases and payroll and billing software systems; our ability to keep our web sites operational at a reasonable cost and without service interruptions; the effect of existing or future government legislation and regulation; our ability to grow and operate our business in compliance with legislation and regulations, including regulations that may affect our clients and, in turn, affect demand for our services, such as Medicare reimbursement rates which may negatively affect both orders and client receivables; the challenge to the classification of certain of our healthcare professionals as independent contractors; the impact of medical malpractice and other claims asserted against us; the disruption or adverse impact to our business as a result of a terrorist attack or breach of security of our data systems; our ability to carry out our business strategy and maintain sufficient cash flow and capital structure to support our business; our ability to meet our financial covenants, which if not met, could adversely affect our liquidity; the loss of key officers and management personnel that could adversely affect our ability to remain competitive; the effect of recognition by us of an impairment to goodwill; our ability to maintain and enhance the brand identities we have developed, at reasonable costs; and the effect of adjustments by us to accruals for self-insured retentions. Other factors that could cause actual results to differ from those implied by the forward-looking statements contained in this earnings release are set forth in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, its Quarterly Reports on Form 10-Q and its Current Reports on Form 8-K. These statements reflect the Company's current beliefs and are based upon information currently available to it. Be advised that developments subsequent to this earnings release are likely to cause these statements to become outdated with the passage of time. The Company does not intend, however, to update the guidance provided today prior to its next earnings release.
AMN Healthcare Services, Inc. Condensed Consolidated Statements of Income (dollars in thousands, except per share amounts) (unaudited) Three Months Ended Twelve Months Ended December 31, December 31, 2008 2007 (1) % Chg 2008 2007 (1) % Chg Revenue $295,902 $285,899 3.5% $1,217,200 $1,164,022 4.6% Cost of revenue 219,966 209,936 4.8% 900,211 860,857 4.6% Gross profit 75,936 75,963 0.0% 316,989 303,165 4.6% 25.7% 26.6% 26.0% 26.0% Expenses: Selling, general and administrative 55,176 55,910 -1.3% 230,656 218,250 5.7% 18.6% 19.6% 18.9% 18.7% Depreciation and amortization 3,581 3,209 11.6% 14,439 11,674 23.7% Total expenses 58,757 59,119 -0.6% 245,095 229,924 6.6% Income from operations 17,179 16,844 2.0% 71,894 73,241 -1.8% 5.8% 5.9% 5.9% 6.3% Interest expense, net 2,669 2,928 -8.8% 10,690 12,457 -14.2% Income before income taxes 14,510 13,916 4.3% 61,204 60,784 0.7% Income tax expense 6,886 5,491 25.4% 26,847 24,403 10.0% Net income $7,624 $8,425 -9.5% $34,357 $36,381 -5.6% 2.6% 2.9% 2.8% 3.1% Net income per common share: Basic $0.23 $0.25 -8.0% $1.03 $1.06 -2.8% Diluted $0.23 $0.25 -8.0% $1.02 $1.04 -1.9% Weighted average common shares outstanding: Basic 32,575 33,828 -3.7% 33,375 34,377 -2.9% Diluted 32,870 34,232 -4.0% 33,811 34,880 -3.1% (1) Net income during the three and twelve months ended December 31, 2007 was revised by $(0.6) million and $(0.2) million for the three and twelve months ended December 31, 2007 to reflect an immaterial correction of an error related to an issue regarding the deductibility of lodging per diem payments for income tax purposes.
AMN Healthcare Services, Inc. Supplemental Financial and Operating Data (dollars in thousands, except operating data) (unaudited) Three Months Ended Twelve Months Ended December 31, December 31, % of % of % of % of 2008 Rev 2007 Rev 2008 Rev 2007 Rev Revenue Nurse and allied health- care staffing $207,313 $196,654 $843,747 $802,034 Locum tenens staffing 76,413 76,179 321,954 310,525 Physician permanent placement services 12,176 13,066 51,499 51,463 $295,902 $285,899 $1,217,200 $1,164,022 Reconciliation of Non-GAAP Items: Adjusted EBITDA(1) Nurse and allied health- care staffing $14,240 6.9% $14,557 7.4% $60,189 7.1% $57,597 7.2% Locum tenens staffing 6,025 7.9% 4,254 5.6% 22,614 7.0% 22,867 7.4% Physician permanent placement Services 2,886 23.7% 3,414 26.1% 12,852 25.0% 12,843 25.0% 23,151 7.8% 22,225 7.8% 95,655 7.9% 93,307 8.0% Depreciation and amortization 3,581 3,209 14,439 11,674 Non-cash stock-based compensation 2,391 2,172 9,322 8,392 Interest expense, net 2,669 2,928 10,690 12,457 Income before income taxes 14,510 13,916 61,204 60,784 Income tax expense 6,886 5,491 26,847 24,403 Net income (2) $7,624 $8,425 $34,357 $36,381
Three Months Twelve Months Ended Ended December 31, 2008 GAAP based diluted earnings per share (EPS) $0.23 $1.02 Adjustments: Sales reserve adjustment 0.01 0.02 Rx Pro Health restructuring and legal expenses 0.00 0.03 0.01 0.05 Pro Forma diluted earnings per share (3) $0.24 $1.06* (*)Amount does not sum due to rounding
Three Months Ended Twelve Months Ended December 31, December 31, 2008 2007 % Chg 2008 2007 % Chg Gross Margin Nurse and allied healthcare staffing 23.6% 24.4% 23.9% 23.8% Locum tenens staffing 26.0% 26.1% 26.3% 26.0% Physician permanent placement services 58.7% 61.8% 59.4% 61.3% Operating Data: Nurse and allied healthcare staffing Average travelers on assignment(4) 6,865 6,645 3.3% 7,036 6,897 2.0% Revenue per traveler per day(5) $328.25 $321.68 2.0% $327.65 $318.60 2.8% Gross profit per traveler per day(5) $77.41 $78.47 -1.4% $78.34 $75.80 3.4% Locum tenens staffing Days filled (6) 53,145 51,639 2.9% 222,341 218,576 1.7% Revenue per day filled(6) $1,437.82 $1,475.22 -2.5% $1,448.02 $1,420.67 1.9% Gross profit per day filled(6) $374.37 $385.62 -2.9% $380.68 $369.73 3.0%
As of December 31, 2008 2007 Leverage Ratio (7) 1.5 1.6 (1) Adjusted EBITDA represents net income plus interest expense (net of interest income), income taxes, depreciation and amortization and non-cash stock-based compensation expense. Management presents adjusted EBITDA because it believes that adjusted EBITDA is a useful supplement to net income as an indicator of operating performance. Management believes that adjusted EBITDA is an industry-wide financial measure that is useful both to management and investors when evaluating the company's performance. Management also uses adjusted EBITDA for planning purposes. Management uses adjusted EBITDA to evaluate the company's performance because it believes that adjusted EBITDA more accurately reflects the company's results, as it excludes certain items, in particular non-cash stock-based compensation charges that management believes are not indicative of the company's operating performance. However, adjusted EBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to operating or net income as an indicator of operating performance, and it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with United States generally accepted accounting principles (GAAP). As defined, adjusted EBITDA is not necessarily comparable to other similarly titled captions of other companies due to potential inconsistencies in the method of calculation. While management believes that some of the items excluded from adjusted EBITDA are not indicative of the company's operating performance, these items do impact the income statement, and management therefore utilizes adjusted EBITDA as an operating performance measure in conjunction with GAAP measures such as net income. (2) Net income during the three months ended December 31, 2007 was revised by $(0.6) million and $(0.2) million respectively, to reflect an immaterial correction of an error related to an issue regarding the deductibility of lodging per diem payments for income tax purposes. (3) Pro forma EPS represents GAAP EPS plus certain restructuring and legal expenses, and sales reserve adjustments. Management presents pro forma EPS because it believes that pro forma EPS is a useful supplement to diluted earnings per share as an indicator of operating performance. Management believes such a measure provides a picture of the company's results that is more comparable among periods since it excludes the impact of items that may recur occasionally, but tend to be irregular as to timing, thereby distorting comparisons between periods. However, investors should note that this non-GAAP measure involves judgment by management (in particular, judgment as to what is classified as a special item to be excluded from pro forma EPS). As defined, pro forma EPS is not necessarily comparable to other similarly titled captions of other companies due to potential inconsistencies in the method of calculation. While management believes that some of the items excluded from pro forma EPS are not indicative of the company's operating performance, these items do impact the income statement, and management therefore utilizes pro forma EPS as an operating performance measure in conjunction with GAAP measures such as GAAP EPS. (4) Average travelers on assignment represents the average number of nurse and allied healthcare professionals on assignment during the period presented. (5) Revenue per traveler per day and gross profit per traveler per day represent the revenue and gross profit of the company's nurse and allied healthcare staffing segment divided by average travelers on assignment, divided by the number of days in the period presented. (6) Days filled is calculated by dividing the locum tenens hours filled during the period by 8 hours. Revenue per day filled and gross profit per day filled represent revenue and gross profit of the company's locum tenens staffing segment divided by days filled for the period presented. (7) Leverage ratio represents the ratio of the total debt outstanding at the end of the period to the Adjusted EBITDA for the past twelve months.
AMN Healthcare Services, Inc. Condensed Consolidated Balance Sheets (in thousands) (unaudited) December 31, September 30, December 31, 2008 2008 2007 (1) Assets Current assets: Cash and cash equivalents $11,316 $7,805 $18,495 Accounts receivable, net 182,562 191,053 184,741 Prepaid expenses 9,523 10,121 9,583 Income taxes receivable 3,440 1,103 - Deferred income taxes, net 18,085 18,113 18,116 Other current assets 4,901 4,233 2,048 Total current assets 229,827 232,428 232,983 Fixed assets, net 24,018 24,645 24,600 Goodwill, net 252,875 252,823 241,266 Intangible assets, net 122,845 124,050 113,535 Deposits and other assets 13,252 14,645 11,274 Total assets $642,817 $648,591 $623,658 Liabilities and stockholders' equity Current liabilities: Bank overdraft $3,995 $457 $- Accounts payable and accrued expenses 24,420 28,126 22,231 Accrued compensation and benefits 44,871 49,976 43,446 Income tax payable - - 2,774 Revolving credit facility 31,500 36,500 - Current portion of notes payable 14,580 14,949 26,616 Deferred revenue 7,184 7,971 7,647 Other current liabilities 14,722 14,567 28,169 Total current liabilities 141,272 152,546 130,883 Notes payable, less current portion 100,236 106,512 120,352 Deferred income taxes, net 58,466 58,962 61,124 Other long-term liabilities 58,710 55,289 45,099 Total liabilities 358,684 373,309 357,458 Stockholders' equity 284,133 275,282 266,200 Total liabilities and stockholders' equity $642,817 $648,591 $623,658 (1) Other current liabilities, other long-term liabilities and stockholder's equity were revised by $2.3 million, $7.6 million and $9.9 million, respectively, as of December 31, 2007, to reflect an immaterial correction of an error related to an issue regarding the deductibility of lodging per diem payments for income tax purposes.
AMN Healthcare Services, Inc. Condensed Consolidated Cash Flow Statement (in thousands) (unaudited) Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2008 2007 2008 2007 Net cash provided by operating activities $13,802 $25,326 $63,694 $79,636 Net cash used in investing activities (1,819) (2,656) (48,247) (14,629) Net cash used in financing activities (8,296) (10,316) (22,334) (50,923) Effect of exchange rates on cash (176) (29) (292) (11) Net increase (decrease) in cash and cash equivalents 3,511 12,325 (7,179) 14,073 Cash and cash equivalents at beginning of period 7,805 6,170 18,495 4,422 Cash and cash equivalents at end of period $11,316 $18,495 $11,316 $18,495
Contact: David C. Dreyer Chief Financial Officer Christopher Powell Director, Investor Relations 866.861.3229
|SOURCE AMN Healthcare Services, Inc.|
Copyright©2009 PR Newswire.
All rights reserved